Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medusa Medical Technologies is a global leader in electronic patient care reporting (ePCR) software, primarily serving the emergency medical services (EMS) and healthcare sectors. The company's flagship product, the Siren ePCR Suite, provides a comprehensive platform for paramedics and emergency responders to document clinical data, track patient outcomes, and manage workflows in real-time. Siren is designed to improve data accuracy and facilitate the seamless transfer of information between pre-hospital providers and hospital emergency departments. Beyond documentation, the platform offers robust analytics and reporting tools to help agencies optimize their clinical and operational performance. Headquartered in Halifax, Nova Scotia, Medusa has established a significant presence in international markets, including the United Kingdom, Australia, and the United States. In 2022, the company was acquired by Logis Solutions to integrate its clinical documentation capabilities with advanced dispatch and resource management technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medusa Medical Technologies.